摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-ethoxy-4-hydroxyphenyl)-1-(2-ethylphenyl)-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-one | 1373492-46-6

中文名称
——
中文别名
——
英文名称
4-(3-ethoxy-4-hydroxyphenyl)-1-(2-ethylphenyl)-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-one
英文别名
4-(3-Ethoxy-4-hydroxy-phenyl)-1-(2-ethyl-phenyl)-1,4,5,7-tetrahydro-pyrazolo[3,4-b]pyridin-6-one;4-(3-ethoxy-4-hydroxyphenyl)-1-(2-ethylphenyl)-5,7-dihydro-4H-pyrazolo[3,4-b]pyridin-6-one
4-(3-ethoxy-4-hydroxyphenyl)-1-(2-ethylphenyl)-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-one化学式
CAS
1373492-46-6
化学式
C22H23N3O3
mdl
——
分子量
377.443
InChiKey
FHXFAMOYGDXNBF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    76.4
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILISATION
    申请人:Oniciu Daniela Carmen
    公开号:US20120129856A1
    公开(公告)日:2012-05-24
    The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.
    本发明涉及一类具有药物活性的杂环化合物及其药物可接受的盐和合物,以及包含它们的组合物。本发明还涉及一种治疗或预防疾病或障碍的方法,其包括向患者施用本文所述化合物的治疗或预防有效量。
  • Compounds, compositions and methods useful for cholesterol mobilisation
    申请人:Cerenis Therapeutics Holding SA
    公开号:US08349833B2
    公开(公告)日:2013-01-08
    The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.
    本发明涉及一类具有药理活性的杂环化合物及其药用可接受盐、合物和包含它们的组合物。本发明还涉及一种治疗或预防疾病或疾病的方法,包括给予本说明书中描述的化合物的治疗或预防有效量。
  • COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION
    申请人:CERENIS THERAPEUTICS HOLDING SA
    公开号:US20130267554A1
    公开(公告)日:2013-10-10
    The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.
    本发明涉及一类具有药物活性的杂环化合物及其药学上可接受的盐和合物,以及包含它们的组合物。本发明还涉及一种治疗或预防疾病或障碍的方法,该方法包括向患者施用本文所述化合物的治疗或预防有效量。
  • Compounds, compositions and methods useful for cholesterol mobilization
    申请人:CERENIS THERAPEUTICS HOLDING SA
    公开号:US09085585B2
    公开(公告)日:2015-07-21
    The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.
    本发明涉及一类具有药理活性的杂环化合物及其药用可接受盐和合物,以及包含它们的组合物。本发明还涉及治疗或预防疾病或疾病的方法,其中包括向受体描述的化合物中施加治疗或预防有效量。
  • EP2629776B1
    申请人:——
    公开号:EP2629776B1
    公开(公告)日:2017-08-16
查看更多